Literature DB >> 10593650

Effect of elevated levels of ornithine decarboxylase on cell cycle progression in skin.

S K Gilmour1, M Birchler, M K Smith, K Rayca, J Mostochuk.   

Abstract

By crossing TG.AC v-Ha-ras and K6/ODC transgenic mice, we found previously that an activated ras and follicular ornithine decarboxylase (ODC) overexpression cooperate to generate spontaneous tumors in the skin. Cellular proliferation was dramatically increased in the K6/ODC transgenic skin, as evidenced by elevated proliferating cell nuclear antigen and Ki67 expression compared with nontransgenic littermates. Keratinocytes isolated from transgenic skin also displayed increased clonal growth. Paradoxically, expression of the growth inhibition-associated proteins p53, p21Waf1, p27Klp1, and Bax was increased with ODC overexpression in the skin. ODC overexpression did not affect cyclin D/cyclin-dependent kinase 4 (Cdk4)-dependent phosphorylation of retinoblastoma protein but stimulated cyclin E/Cdk2 and cyclin A/Cdk2-associated kinase activity, with minimal effect on the levels of these proteins. Thus, ODC/polyamine-induced activation of cyclin E/Cdk2 and cyclin A/Cdk2-associated kinase activity may cooperate with the ras induction of cyclin D/Cdk4/6-associated retinoblastoma protein phosphorylation to not only stimulate proliferation but ultimately contribute to tumor development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10593650

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  11 in total

1.  Elevated ornithine decarboxylase activity promotes skin tumorigenesis by stimulating the recruitment of bulge stem cells but not via toxic polyamine catabolic metabolites.

Authors:  Candace S Hayes; Karen DeFeo-Mattox; Patrick M Woster; Susan K Gilmour
Journal:  Amino Acids       Date:  2013-07-25       Impact factor: 3.520

2.  A prolonged and exaggerated wound response with elevated ODC activity mimics early tumor development.

Authors:  Candace S Hayes; Karen Defeo; Hong Dang; Carol S Trempus; Rebecca J Morris; Susan K Gilmour
Journal:  Carcinogenesis       Date:  2011-07-05       Impact factor: 4.944

3.  Hairless and the polyamine putrescine form a negative regulatory loop in the epidermis.

Authors:  Courtney T Luke; Alexandre Casta; Hyunmi Kim; Angela M Christiano
Journal:  Exp Dermatol       Date:  2013-10       Impact factor: 3.960

4.  A definitive role of ornithine decarboxylase in photocarcinogenesis.

Authors:  N Ahmad; A C Gilliam; S K Katiyar; T G O'Brien; H Mukhtar
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

Review 5.  Polyamines and nonmelanoma skin cancer.

Authors:  Susan K Gilmour
Journal:  Toxicol Appl Pharmacol       Date:  2006-11-29       Impact factor: 4.219

6.  Elevated ornithine decarboxylase levels activate ataxia telangiectasia mutated-DNA damage signaling in normal keratinocytes.

Authors:  Gang Wei; Karen DeFeo; Candace S Hayes; Patrick M Woster; Laura Mandik-Nayak; Susan K Gilmour
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

7.  Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/- mice.

Authors:  Xiuwei Tang; Arianna L Kim; David J Feith; Anthony E Pegg; Justin Russo; Hong Zhang; Michelle Aszterbaum; Levy Kopelovich; Ervin H Epstein; David R Bickers; Mohammad Athar
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

8.  ATP13A3 and caveolin-1 as potential biomarkers for difluoromethylornithine-based therapies in pancreatic cancers.

Authors:  Meenu Madan; Arjun Patel; Kristen Skruber; Dirk Geerts; Deborah A Altomare; Otto Phanstiel Iv
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

9.  The biological response of spermidine induced by ionization radiation.

Authors:  Changhyun Roh; Dong-Kyung Yu; Insub Kim; Sung Kee Jo
Journal:  Molecules       Date:  2011-12-23       Impact factor: 4.411

Review 10.  Skin Carcinogenesis Studies Using Mouse Models with Altered Polyamines.

Authors:  Shannon L Nowotarski; David J Feith; Lisa M Shantz
Journal:  Cancer Growth Metastasis       Date:  2015-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.